ATXS icon

Astria Therapeutics
ATXS

Overview Fund Activity

100 hedge funds and large institutions have $506M invested in Astria Therapeutics in 2024 Q2 according to their latest regulatory filings, with 23 funds opening new positions, 39 increasing their positions, 27 reducing their positions, and 25 closing their positions.

Holders
100
Holders Change
-2
Holders Change %
-1.96%
% of All Funds
1.45%
Holding in Top 10
1
Holding in Top 10 Change
-2
Holding in Top 10 Change %
-66.67%
% of All Funds
0.01%
New
23
Increased
39
Reduced
27
Closed
25
Calls
$215K
Puts
$577K
Net Calls
-$362K
Net Calls Change
-$42.7M

Top Buyers

1
VPC
1
Vestal Point Capital
New York
$29.6M
2
Fidelity Investments
2
Fidelity Investments
Massachusetts
$55.1M
3
NCM
3
Nantahala Capital Management
Connecticut
$6.14M
4
RCM
4
RA Capital Management
Massachusetts
$45.9M
5
Citadel Advisors
5
Citadel Advisors
Florida
$12.9M

Top Sellers

1
TCM
1
TCG Crossover Management
California
$25.1M
2
CAM
2
Cormorant Asset Management
Massachusetts
$0
3
APM
3
Avidity Partners Management
Texas
$0
4
AG
4
Artal Group
Luxembourg
$0
5
Adage Capital Partners
5
Adage Capital Partners
Massachusetts
$7.46M
Name Market Value Shares Shares
Change 		Shares
Change %
Nomura Holdings
126
Nomura Holdings
Japan
– – – –
GS
127
GTS Securities
New York
– – – –
CFGS
128
Concourse Financial Group Securities
Alabama
– – – –
Wolverine Trading
129
Wolverine Trading
Illinois
– – – –
2 3 4 5
6